PALATINE, Ill., March 26, 2009 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (Nasdaq:ACUR) is pleased to announce that Garth Boehm, Ph.D. has been named Vice President, Modified Release Dosage Form Development. Dr. Boehm, is currently employed as Vice President of Product Development at Actavis Pharmaceuticals and is expected to commence employment with Acura in May 2009.
